Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Chan-Young Ock
High Tumoral PD-L1 Expression and Low PD-1+ or CD8+ Tumor-Infiltrating Lymphocytes Are Predictive of a Poor Prognosis in Primary Diffuse Large B-Cell Lymphoma of the Central Nervous System
OncoImmunology
Oncology
Allergy
Immunology
Metabolic Landscape of Advanced Gastric Cancer According to HER2 and Its Prognostic Implications
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
Related publications
PD-L1 Expression and Combined Status of PD-L1/PD-1–Positive Tumor Infiltrating Mononuclear Cell Density Predict Prognosis in Glioblastoma Patients
Journal of Pathology and Translational Medicine
Forensic Medicine
Pathology
Histology
The Significance of Pd-L1 and Pd1 Receptors Expression in Patients With Diffuse B-Cell Large-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PD-L1 Expression in Basaloid Squamous Cell Lung Carcinoma: Relationship to PD-1+ and CD8+ Tumor-Infiltrating T Cells and Outcome
Modern Pathology
Forensic Medicine
Pathology
Tumour-Infiltrating Lymphocytes Are Correlated With Higher Expression Levels of PD-1 and PD-L1 in Early Breast Cancer
ESMO Open
Cancer Research
Oncology
Prognostic Implication of Programmed Death-1-Positive Tumor-Infiltrating Lymphocytes in Diffuse Large B-Cell Lymphoma
The Korean Journal of Pathology
Prognostic Impact of Pd-L1 Expression, Double Expressor Lymphoma, and Progression of Disease Within 24 Months in Primary Gastrointestinal Diffuse Large B-Cell Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
PD-L1 Expression Combined With Microsatellite Instability/Cd8+ Tumor Infiltrating Lymphocytes as a Useful Prognostic Biomarker in Gastric Cancer
Scientific Reports
Multidisciplinary
Prognostic Significance of Pd-L1 and Phosphorylated Erk Expression in T-Cell Lymphoma: Pd-1/Pd-L1 Axis Activates Intracellular Erk Signaling in Tumor Cells
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
A2aR AS ONE OF NOVEL IMMUNE CHECKPOINTS, AND TUMOR-INFILTRATING LYMPHOCYTES IN DIFFUSE LARGE B-Cell LYMPHOMA
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology